Status:
COMPLETED
Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged Skin
Lead Sponsor:
Galderma R&D
Conditions:
Photoaged Skin
Eligibility:
All Genders
30+ years
Phase:
PHASE2
Brief Summary
Skin photoaging or skin photodamage were terms used to describe the change in the structure, function and appearance of skin caused by prolonged and repeated exposure to sunlight or other ultraviolet ...
Detailed Description
Different application times of the study treatment were being investigated.
Eligibility Criteria
Inclusion
- Male or female participants older than 30 years of age.
- Participants with a photodamage grade of at least 4 on the Griffiths photonumeric scale (symmetrical photodamage on the two target areas)
- Participants with mottled hyper-pigmentation on the face
- Participants willing and capable of cooperating to the extent and degree required by the protocol
- Participants must read the Patient Information Sheet and read and sign the Informed Consent form prior to any study related procedures.
Exclusion
- Participants who were at risk in terms of precautions, warnings, and contra-indication in the package insert for Metvix
- Participants with suspected porphyria
- Participants with specific wash-out period for interfering treatments
- Participants requiring concurrent treatment that would interfere with study objectives and/or evaluations
Key Trial Info
Start Date :
April 18 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00437320
Start Date
April 18 2007
End Date
September 1 2008
Last Update
May 31 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinico Ruber
Madrid, Spain
2
Whittington Hospital
London, United Kingdom
3
University of Manchester-Hope Hospital
Manchester, United Kingdom